SCHEMBL919863

SCHEMBL919863

[c]1cccc(Sc2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.45
MAOB P27338 3/20 0.45
HPGD P15428 4/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MGLL Q99685 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HTR2C P28335 2/20 0.34
HTR6 P50406 1/20 0.34
SLC6A4 P31645 1/20 0.34
MCL1 Q07820 2/20 0.33
MAPK1 P28482 1/20 0.33
CHRNA7 P36544 1/20 0.32
BCL2 P10415 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HTT P42858 1/20 0.31
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8155628 0.93 MAOA (0.34) MAOAMAOBHPGDMAPTSMN1; SMN2
SCHEMBL9686247 0.83 MAOA (0.35) MAOAMAOBALDH1A1MAPTMAPK1
SCHEMBL27316073 0.83 MAOA (0.47) MAOAMAOBHPGDALDH1A1MAPT
SCHEMBL4795784 0.83 MLYCD (0.42) MAOAMAOBHPGDALDH1A1MAPT
Diphenylsulfane SCHEMBL2473224 0.79 MAOA (0.62) MAOAMAOBHPGDALDH1A1MAPT
Diphenylsulfane SCHEMBL27841257 0.79 MAOA (0.62) MAOAMAOBHPGDALDH1A1MAPT
SCHEMBL8564978 0.78 PTGIR (0.36) MAOAMAOBALDH1A1MAPTSMN1; SMN2
SCHEMBL6553951 0.78 PTGIR (0.45) MAPTHTR2C
SCHEMBL237662 0.77 MAOA (0.50) MAOAMAOBHPGDALDH1A1MAPT
Diphenylsulfane SCHEMBL28332331 0.76 HPGD (0.60) MAOAMAOBHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors ASTEX THERAPEUTICS LTD. (GB) 2009-08-27 US claimed
EP-2049497-A2 PYRIMIDINE DERIVATIVES AS HSP90 INHIBITORS Astex Therapeutics Limited (GB) 2009-04-22 EP claimed
WO-2006123165-A2 PYRIMIDINE DERIVATIVES AS HSP90 INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2006-11-23 WO claimed
US-20240239922-A1 PHOTOCURABLE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-07-18 US disclosed
US-20240192593-A1 PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-06-13 US disclosed
US-20240191003-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-06-13 US disclosed
CN-117999296-A Composition and photosensitive composition 东京应化工业株式会社 2024-05-07 CN disclosed
CN-117980346-A Composition and photosensitive composition 东京应化工业株式会社 2024-05-03 CN disclosed
CN-117980347-A Photosensitive composition 东京应化工业株式会社 2024-05-03 CN disclosed
CN-117908326-A Photosensitive composition 东京应化工业株式会社 2024-04-19 CN disclosed
CN-117908327-A Composition and photosensitive composition 东京应化工业株式会社 2024-04-19 CN disclosed
US-4767443-A Antifungal and antibacterial diazine derivatives compositions, intermediates, and method of use therefor CIBA-GEIGY CORPORATION (US) 1988-08-30 US disclosed
EP-0263229-A1 Phenol derivatives, their preparation and the use thereof OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1988-04-13 EP disclosed
EP-0249015-A1 Silane derivatives, process for their preparation, agents containing them, and their use as pesticides HOECHST AKTIENGESELLSCHAFT (DE) 1987-12-16 EP disclosed
EP-0224024-A1 Silane derivatives, process for their preparation, agents containing them and their use as pesticides HOECHST AKTIENGESELLSCHAFT (DE) 1987-06-03 EP disclosed
EP-0175651-A1 Microbicides CIBA-GEIGY AG (CH) 1986-03-26 EP disclosed
US-4344961-A MITICIDES BASF AKTIENGESELLSCHAFT (DE) 1982-08-17 US disclosed
EP-0012273-A1 Carboxylic acid esters, process for their preparation and their use as pesticides BASF Aktiengesellschaft (DE) 1980-06-25 EP disclosed
US-4044149-A ANTIINFLAMMATORY ELI LILLY AND COMPANY (US) 1977-08-23 US disclosed
US-3976674-A ANTIINFLAMMATORY ELI LILLY AND COMPANY (US) 1976-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240192593-A1 PHOTOSENSITIVE COMPOSITION PPOX, ERCC1, ERCC5 MAOA 1098/4885MAOB 1102/4885HPGD 1133/4885
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors HSP90AB1, HSP90AB2P, HSP90B1 MAOA 2662/4885MAOB 2177/4885HPGD 1647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.